Thursday, September 10, 2026
The Cancer News

AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER

Brandon G. Smaglo, MD

Brandon G. Smaglo, MD

an oncologist

MD Anderson Cancer Center in Houston, Texas, specializing in the treatment of pancreatic cancers

Published Articles (1)

RASolute 302: A Turning Point for RAS-Targeted Therapy in Pancreatic Cancer

July 24, 2026

The 2026 ASCO Annual Meeting brought what may be the most significant pancreatic cancer data in years: